Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study.
Journal: Journal of thrombosis and thrombolysis
Published: August 30, 2022
Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences.
Journal: Advances in therapy
Published: August 19, 2022
Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study.
Journal: Journal of thrombosis and thrombolysis
Published: March 17, 2022
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.
Journal: Thrombosis and haemostasis
Published: December 28, 2021
Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries.
Journal: PloS one
Published: December 01, 2021
Correction to: Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY.
Journal: Advances in therapy
Published: July 09, 2021
Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status.
Journal: Advances in therapy
Published: June 29, 2021
Effectiveness and safety of apixaban, LMWH, and warfarin among high-risk subgroups of VTE patients with active cancer.
Journal: Current medical research and opinion
Published: May 25, 2021
Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY.
Journal: Advances in therapy
Published: December 08, 2020
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity.
Journal: Journal of clinical medicine
Published: November 13, 2020
Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis.
Journal: Thrombosis and haemostasis
Published: November 10, 2020
Last Updated: 09/26/2026